We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App





Horiba Showcases HELO Global Hematology Solution at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 07 Feb 2023
Print article
Image: HELO Global Hematology Solution fulfills all the needs of a high throughput automated hematology platform (Photo courtesy of Horiba)
Image: HELO Global Hematology Solution fulfills all the needs of a high throughput automated hematology platform (Photo courtesy of Horiba)

Horiba Medical (Kyoto, Japan) is showcasing its extensive and comprehensive line of hematology, hemostasis, and clinical chemistry solutions, including analyzers, reagents, and consumables, for in vitro diagnostics at Medlab Middle East 2023.

At this year’s Medlab Middle East, Horiba is presenting HELO (HORIBA Evolutive Laboratory Organization), its global hematology solution. With an innovative design solution covering all the needs of a high throughput automated hematology platform, the flexible and efficient HELO is the optimum answer to the constant evolution of laboratories. The HORIBA advanced technologies embedded in the Yumizen H2500/H1500 associated with over 30 years of experience in hematology diagnosis offer the highest analytical performances. Thanks to its data, tube management, blood film, and digitalization management capability, HELO not only addresses all needs but also helps optimize TAT, floor space and reagent storage. HELO comes with Horiba’s accreditation assistance program which has been developed in accordance with ISO-15189 certification.

Horiba is also showcasing the new Yumizen H500 and H550 compact benchtop hematology analyzers with enhanced performance, new features, and increased benefits, alongside the Microsemi CRP LC-767G hematology analyzer that enables simultaneous blood analysis + CRP measurement, along with data management. In addition, Horiba is highlighting the Yumizen G1550/G1500 automated hemostasis analyzer that offers routine and specialized testing in a single analysis system, alongside the Yumizen G400 semi-automated hemostasis analyzer that offers a smart way to test with four independent measuring channels and 20 incubation positions.

Among its clinical chemistry solutions, Horiba is presenting the Pentra C200 clinical chemistry analyzer with fixed cycles that provides a continuous throughput of 90 colorimetric tests/hour, alongside the Pentra C400 clinical chemistry analyzer that features 55 on-board assays, an innovative cassette format, and integrated workstation and validation station. Among its laboratory automation solutions, Horiba is showcasing the Yumizen T6000 automated rack conveyor that is fully compatible with laboratory architecture (spaces, walls, columns) due to wide configurations of panels (linear, work cell, angular, island), alongside the Cube S robotic workstation that manages pre and post-analytical sorting, storing, and tracking of sample tubes in a laboratory.

Related Links:
Horiba Medical

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.